Explore the transformative impact of radiotherapy in skin cancer management, focusing on the three Cs: Cure, Cosmesis, and Convenience. This webinar offers dermatologists and GPs practical insights into radiotherapy practices to optimise patient outcomes for...
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
While the gold standard for treating non-melanoma skin cancer continues to be Mohs surgery, the number of patients who are good candidates for radiation therapy has been increasing dramatically in recent years, especially in the cohort of patients who are highly...
The Xstrahl 200 X-ray Treatment System has been installed in Uzbekistan by Nozomi Medical. Hear Dr. Mamarasulov provide his feedback and review of the Xstrahl 200.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
Xstrahl presented The role of radiation technologists as a radiotherapy treatment at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 2024 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in Washington, DC Sept. 29-Oct 2, 2024, at booth #1937.
In this webinar, Kurt Byrnes, Radiation Oncology Medical Physicist at Just Skin in Australia provides an overview of his experience of commissioning grenz rays on the Xstrahl X100 system following the AAPM TG61 protocol. He covers protocol comparison, half value layer...
Accurate dosimetry and reporting is the best practice in radiation research. Based on a powerful Monte Carlo dose engine, SmART-RAD is an easy-to-use solution that gives users the tools to determine and understand how irradiation parameters impact the delivered dose....
Contact Us